Statements (58)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:bfsLayer |
6
|
gptkbp:bfsParent |
gptkb:rubella
|
gptkbp:caused_by |
gptkb:rubella
|
gptkbp:clinical_trial |
mild illness in children
more severe in adults |
gptkbp:collaborations |
elimination programs
|
gptkbp:complications |
gptkb:congenital_rubella_syndrome
|
gptkbp:data_usage |
higher in unvaccinated populations
|
gptkbp:discovered_by |
gptkb:1962
|
gptkbp:family |
gptkb:Togaviridae
|
gptkbp:genus |
gptkb:Rubivirus
|
gptkbp:healthcare |
promoting vaccination
reduction in congenital rubella syndrome |
gptkbp:historical_significance |
linked to birth defects
|
https://www.w3.org/2000/01/rdf-schema#label |
rubella virus
|
gptkbp:incubation_period |
2 to 3 weeks
|
gptkbp:is_affected_by |
pregnant women
|
gptkbp:is_compared_to |
varies by region
|
gptkbp:is_monitored_by |
mandatory reporting in many countries
|
gptkbp:is_protected_by |
vaccination
|
gptkbp:is_tested_for |
Ig M antibodies
Ig G seroconversion |
gptkbp:is_vulnerable_to |
gptkb:MMR_vaccine
live attenuated 95% or higher lifelong after infection second dose at 4-6 years first dose at 12-15 months introduced in 1969 routine childhood vaccination MR vaccine post-vaccination preconception vaccination |
gptkbp:origin |
respiratory epithelium
fetal tissues |
gptkbp:public_awareness |
importance of vaccination
|
gptkbp:research_focus |
genetic diversity
vaccine development |
gptkbp:risk_factor |
travel to endemic areas
lack of vaccination |
gptkbp:seed_dispersal |
single-stranded RNA
|
gptkbp:social_responsibility |
gptkb:measles
global distribution serological testing mumps PCR testing isolation during outbreaks reported in unvaccinated populations |
gptkbp:social_structure |
icosahedral symmetry
enveloped |
gptkbp:status |
elimination in some regions
|
gptkbp:symptoms |
fever
rash lymphadenopathy |
gptkbp:transmission |
airborne droplets
|
gptkbp:treatment |
supportive care
no specific antiviral treatment |